Astera Labs Director Stefan Dyckerhoff Disposes of $3.44M in Common Stock via Rule 10b5-1 Plan
Astera Labs, Inc.
Subscribe to track ALAB
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
🚨 INSIDER TRANSACTION ALERT - Astera Labs, Inc. ($ALAB)
Insider: Stefan A. Dyckerhoff (Director)
Transaction: Sale of 12,500 shares
Average Price: ~$274.96
Total Value: ~$3,437,030
Date: 2026-09-02
Type: Pre-arranged Rule 10b5-1 Plan (Adopted Dec 1, 2025)
Shares Remaining: ~367,325 shares (across direct & indirect accounts)
Comprehensive Analysis
Insider Trading Summary: Astera Labs, Inc. (ALAB)
Stefan A. Dyckerhoff, a member of the Board of Directors at Astera Labs, Inc., reported dispositions totaling 12,500 shares of Common Stock on September 2, 2026, for an aggregate value of approximately $3,437,029.71.
Key Details:
- Transaction Structure: Dispositions occurred across four weighted average price tiers ranging between $273.27 and $277.12 per share.
- Direct vs. Indirect Holdings Transacted:
- Direct: 3,505 shares sold (50,456 direct shares retained post-transactions).
- Trust Holdings: 8,333 shares sold (294,733 shares retained).
- Limited Partnership Holdings: 661 shares sold (3,309 shares retained).
- Trading Plan: All sales were executed in accordance with a Rule 10b5-1 trading plan previously adopted on December 1, 2025.
- Remaining Holdings: Dyckerhoff continues to hold beneficial interest in over 367,000 shares across direct, trust, and limited partnership entities.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.